How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?

Chron Respir Dis · 2023 · PMC10903204 · PMID 37800633

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

12 Nonetheless, both subgroups demonstrated significant improvements in trough FEV 1 and symptoms (SAC-TDI and E-RS score) with dual versus monotherapy, although improvements in symptoms outcomes did not reach statistical significance in high SABA users.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.